Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Texan Who Shouldn’t Play a Role in the Trump Administration Is Rumored to Be Interviewing Today for EPA Administrator November 28, 2016
Could Texas’ Continued Defiance of EPA on Regulation of Greenhouse Gases Be Costly Posturing? August 12, 2010